Accueil   Calls for projects   Innovative Medicines Initiative - Call 12

Innovative Medicines Initiative – Call 12

The Innovative Medicines Initiative - IMI2 (2014-2020) has launched its 12th call for proposal.

Key features of the call for projects

Type de l'appel : Collaboratif

Porteur(s) de projet : Académique, Clinique, ETI, PME

Opening date: July 19th, 2017

Date de clôture : October 24th, 2017

Dimension : Europe


Type de financement : Subvention

Appel d'offre thématisé

Thématique(s) médicale(s) : Animal health, Auto-immunes diseases, CNS-related diseases, Essais cliniques @en, Essais pré cliniques @en, Genetic and rare diseases, Human health, Immunology, Infectiology - Infectious diseases, Inflammatory diseases, Metabolic diseases, Micro and nano technologies, Oncology, Orphan diseases

Secteur(s) industriel(s) :



IMI 2014IMI (Innovative Medicines Initiative) is a public -private partnership between the pharmaceutical members of EFPIA ( European Federation of Pharmaceutical Industries and Associations) and the European Commission.


It aims is to financially support the pan-European research collaborations in the field of innovative medicines in order to increase security and efficiency.



The topics open are:


For full details of these topics, including the budget breakdown and the General Conditions for the Call for proposals, please click on the links above (which take you directly to the relevant page of the Participant Portal), or read the IMI2 Call 12 Topics Text  


Indicative budget

  • From EFPIA companies and IMI2 Associated Partners: EUR 62 362 000
  • From the IMI2 JU: EUR 64 077 000
Key dates
  • Publication date: 19 July 2017
  • Stage 1 submission start date: 19 July 2017
  • Stage 1 submission deadline: 24 October 2017 – 17:00:00 Brussels time
  • Stage 2 submission deadline: 16 May 2018 – 17:00:00 Brussels time


Webinars are also regularly organized to help you build your project. 


IMI strongly encourages SMEs, patient organizations , regulatory authorities , academic teams , industry , hospitals and other organizations with an interest in IMI projects to participate in webinars . Lyonbiopole supports you for your European projects.


Learn more about IMI